Primary IOL implantation in pediatric open globe injuries with active inflammation showed inferior visual outcomes compared ...

Johnson & Johnson (NYSE:JNJ) received FDA approval for its TECNIS PureSee IOL, an extended depth of focus intraocular lens ...

The TECNIS PureSee IOL addresses both cataract-related vision loss and presbyopia, which affects near vision as eyes age.

FDA approval supports US commercialization of TECNIS PureSee, an EDOF IOL for implantation during cataract surgery, with availability anticipated later in 2026. PureSee is positioned to preserve ...

The Tecnis PureSee IOL is the first FDA-approved extended depth of focus IOL maintaining contrast sensitivity comparable to ...

Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients ...

-- Results from a 12-country survey of more than 75,000 patients shows limited patient awareness about cataract disease and available treatment options -- New findings presented at the XXXV European ...

Most people have a relative, friend or neighbor who has had to deal with a cataract. Nearly 24.5 million Americans age 40 or older are affected by cataracts, and it’s the leading cause of blindness ...

Cataract surgery remains one of the most frequently performed and successful surgical procedures worldwide, involving the removal of a clouded natural lens and its replacement with an intraocular lens ...

Pune, India-- (SBWIRE) -- 02/21/2019-- Cataract is an eye disease which causes the formation of a dense and cloudy area in the lens of the eye, mostly as a result of the aging process. Around 90% of ...

Aging is a natural part of life, and as we grow older, our bodies go through various changes. Our hair turns gray, our joints ache a bit more and our energy levels fluctuate. But one aspect of aging ...